IBT — International Biotechnology Trust Cashflow Statement
0.000.00%
Last trade - 00:00
FinancialsConservativeSmall Cap
- £232.46m
- £264.94m
- £12.06m
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.4 | 53.6 | 28 | -22.3 | 6.93 |
Non-Cash Items | 25.7 | -64.9 | -43.1 | 23.4 | 19.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.75 | 1.72 | 0.533 | 0.062 | 0.946 |
Change in Accounts Receivable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 6.47 | -9.55 | -14.5 | 1.12 | 27.3 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -5.35 | -9.11 | 12 | -16.4 | -21.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.12 | -18.7 | -2.54 | -19.7 | 7.5 |